GILTERITINIB (Xospata) Nursing Considerations

What is the generic name?

GILTERITINIB

What is the Trade Name for GILTERITINIB?

Xospata

What are the Indications for GILTERITINIB?

• 1 INDICATIONS AND USAGE XOSPATA is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. ( 1.1 ) 1.1 Relapsed or Refractory Acute Myeloid Leukemia XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.

References: https://open.fda.gov/